• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

APOL1 C 末端变异体可能通过干扰 APOL3 对肌动球蛋白的控制引发肾脏疾病。

APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.

机构信息

Laboratory of Molecular Parasitology, IBMM, Université Libre de Bruxelles, 6041 Gosselies, Belgium.

Laboratory of Experimental Medicine (ULB222), CHU Charleroi, Université Libre de Bruxelles, Montigny le Tilleul, Belgium.

出版信息

Cell Rep. 2020 Mar 17;30(11):3821-3836.e13. doi: 10.1016/j.celrep.2020.02.064.

DOI:10.1016/j.celrep.2020.02.064
PMID:32187552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7090385/
Abstract

The C-terminal variants G1 and G2 of apolipoprotein L1 (APOL1) confer human resistance to the sleeping sickness parasite Trypanosoma rhodesiense, but they also increase the risk of kidney disease. APOL1 and APOL3 are death-promoting proteins that are partially associated with the endoplasmic reticulum and Golgi membranes. We report that in podocytes, either APOL1 C-terminal helix truncation (APOL1Δ) or APOL3 deletion (APOL3KO) induces similar actomyosin reorganization linked to the inhibition of phosphatidylinositol-4-phosphate [PI(4)P] synthesis by the Golgi PI(4)-kinase IIIB (PI4KB). Both APOL1 and APOL3 can form K channels, but only APOL3 exhibits Ca-dependent binding of high affinity to neuronal calcium sensor-1 (NCS-1), promoting NCS-1-PI4KB interaction and stimulating PI4KB activity. Alteration of the APOL1 C-terminal helix triggers APOL1 unfolding and increased binding to APOL3, affecting APOL3-NCS-1 interaction. Since the podocytes of G1 and G2 patients exhibit an APOL1Δ or APOL3KO-like phenotype, APOL1 C-terminal variants may induce kidney disease by preventing APOL3 from activating PI4KB, with consecutive actomyosin reorganization of podocytes.

摘要

载脂蛋白 L1(APOL1)的 C 端变体 G1 和 G2 赋予人类抵抗罗得西亚锥虫(Trypanosoma rhodesiense)睡眠病寄生虫的抗性,但它们也增加了患肾病的风险。APOL1 和 APOL3 是促进细胞死亡的蛋白质,它们部分与内质网和高尔基体膜相关联。我们报告在足细胞中,APOL1 C 端螺旋截断(APOL1Δ)或 APOL3 缺失(APOL3KO)诱导类似的肌动球蛋白重排,这与高尔基体 PI(4)激酶 IIIB(PI4KB)抑制磷脂酰肌醇-4-磷酸 [PI(4)P] 的合成有关。APOL1 和 APOL3 都可以形成 K 通道,但只有 APOL3 表现出对神经元钙传感器-1(NCS-1)的高亲和力 Ca 依赖性结合,促进 NCS-1-PI4KB 相互作用并刺激 PI4KB 活性。APOL1 C 端螺旋的改变触发 APOL1 展开和与 APOL3 的结合增加,影响 APOL3-NCS-1 的相互作用。由于 G1 和 G2 患者的足细胞表现出 APOL1Δ 或 APOL3KO 样表型,APOL1 C 端变体可能通过阻止 APOL3 激活 PI4KB 来诱导肾病,随后足细胞的肌动球蛋白重排。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/0e19797cb51e/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/16754f9a844f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/5d9acb2999bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/c38f7e00d185/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/53f2198f2f68/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/0badc74e7a24/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/a4e4956b5856/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/e95551d92942/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/0e19797cb51e/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/16754f9a844f/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/5d9acb2999bd/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/c38f7e00d185/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/53f2198f2f68/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/0badc74e7a24/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/a4e4956b5856/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/e95551d92942/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/257a/7090385/0e19797cb51e/gr7.jpg

相似文献

1
APOL1 C-Terminal Variants May Trigger Kidney Disease through Interference with APOL3 Control of Actomyosin.APOL1 C 末端变异体可能通过干扰 APOL3 对肌动球蛋白的控制引发肾脏疾病。
Cell Rep. 2020 Mar 17;30(11):3821-3836.e13. doi: 10.1016/j.celrep.2020.02.064.
2
The function of apolipoproteins L (APOLs): relevance for kidney disease, neurotransmission disorders, cancer and viral infection.载脂蛋白L(APOLs)的功能:与肾脏疾病、神经传递障碍、癌症及病毒感染的相关性。
FEBS J. 2021 Jan;288(2):360-381. doi: 10.1111/febs.15444. Epub 2020 Jun 25.
3
The Mechanism of Kidney Disease Due to APOL1 Risk Variants.APOL1风险变异导致肾脏疾病的机制。
J Am Soc Nephrol. 2020 Nov;31(11):2502-2505. doi: 10.1681/ASN.2020070954. Epub 2020 Sep 17.
4
Apolipoproteins L1 and L3 control mitochondrial membrane dynamics.载脂蛋白 L1 和 L3 控制线粒体膜动态。
Cell Rep. 2023 Dec 26;42(12):113528. doi: 10.1016/j.celrep.2023.113528. Epub 2023 Dec 2.
5
APOL1 variant-associated kidney disease: from trypanosomes to podocyte cytoskeleton.载脂蛋白L1(APOL1)变异相关肾病:从锥虫到足细胞细胞骨架
Kidney Int. 2020 Dec;98(6):1373-1377. doi: 10.1016/j.kint.2020.07.034. Epub 2020 Aug 22.
6
The Janus-faced functions of Apolipoproteins L in membrane dynamics.载脂蛋白 L 在膜动力学中的双面功能。
Cell Mol Life Sci. 2024 Mar 13;81(1):134. doi: 10.1007/s00018-024-05180-9.
7
Distinct APOL1 functions in trypanosomes and kidney podocytes.在锥虫和肾脏足细胞中具有不同的 APOL1 功能。
Trends Parasitol. 2022 Feb;38(2):104-108. doi: 10.1016/j.pt.2021.11.005. Epub 2021 Dec 6.
8
Structural characterization of the C-terminal coiled-coil domains of wild-type and kidney disease-associated mutants of apolipoprotein L1.载脂蛋白L1野生型及与肾病相关的突变体C末端卷曲螺旋结构域的结构表征
FEBS J. 2016 May;283(10):1846-62. doi: 10.1111/febs.13706. Epub 2016 Apr 1.
9
APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.APOL1 风险变异通过增强内质网应激导致足细胞损伤。
Biosci Rep. 2018 Aug 29;38(4). doi: 10.1042/BSR20171713. Print 2018 Aug 31.
10
Structures of the ApoL1 and ApoL2 N-terminal domains reveal a non-classical four-helix bundle motif.ApoL1 和 ApoL2 N 端结构域的结构揭示了一种非经典的四螺旋束基序。
Commun Biol. 2021 Jul 27;4(1):916. doi: 10.1038/s42003-021-02387-5.

引用本文的文献

1
Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury.载脂蛋白L1(APOL1):对分子进化、与APOL3相互作用以及剪接异构体影响的思考推动了对细胞损伤的细胞和分子机制的理解。
Cells. 2025 Jul 2;14(13):1011. doi: 10.3390/cells14131011.
2
A Cell Biologist's View on APOL1: What We Know and What We Still Need to Address.一位细胞生物学家对载脂蛋白L1(APOL1)的看法:我们所知道的以及仍需解决的问题。
Cells. 2025 Jun 24;14(13):960. doi: 10.3390/cells14130960.
3
Apolipoprotein L2's Role in Liver Fibrosis.

本文引用的文献

1
Alterations in plasma membrane ion channel structures stimulate NLRP3 inflammasome activation in APOL1 risk milieu.血浆膜离子通道结构的改变刺激 APOL1 风险环境中的 NLRP3 炎性小体激活。
FEBS J. 2020 May;287(10):2000-2022. doi: 10.1111/febs.15133. Epub 2019 Dec 2.
2
APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice.APOL1 肾风险变异体促进 APOL1 转基因小鼠组织和培养巨噬细胞中的胆固醇积累。
PLoS One. 2019 Apr 18;14(4):e0211559. doi: 10.1371/journal.pone.0211559. eCollection 2019.
3
ATG9A shapes the forming autophagosome through Arfaptin 2 and phosphatidylinositol 4-kinase IIIβ.
载脂蛋白L2在肝纤维化中的作用。
Gastro Hep Adv. 2025 Mar 27;4(7):100665. doi: 10.1016/j.gastha.2025.100665. eCollection 2025.
4
Targeting symbionts by apolipoprotein L proteins modulates gut immunity.载脂蛋白L蛋白靶向共生菌可调节肠道免疫。
Nature. 2025 May 14. doi: 10.1038/s41586-025-08990-4.
5
Targeting the Type I Interferon Pathway in Glomerular Kidney Disease: Rationale and Therapeutic Opportunities.靶向肾小球肾病中的I型干扰素通路:原理与治疗机会
Kidney Int Rep. 2024 Oct 21;10(1):29-39. doi: 10.1016/j.ekir.2024.10.013. eCollection 2025 Jan.
6
Apolipoprotein-L Functions in Membrane Remodeling.载脂蛋白-L在膜重塑中的功能。
Cells. 2024 Dec 20;13(24):2115. doi: 10.3390/cells13242115.
7
Apolipoprotein-L1 (APOL1): From Sleeping Sickness to Kidney Disease.载脂蛋白 L1(APOL1):从昏睡病到肾病。
Cells. 2024 Oct 20;13(20):1738. doi: 10.3390/cells13201738.
8
Pathogenesis of HIV-associated nephropathy in children and adolescents: taking a hard look 40 years later in the era of gene-environment interactions.儿童和青少年HIV相关性肾病的发病机制:40年后在基因-环境相互作用时代的深入审视
Am J Physiol Renal Physiol. 2024 Dec 1;327(6):F1049-F1066. doi: 10.1152/ajprenal.00208.2024. Epub 2024 Sep 26.
9
The Mechanism of Kidney Disease due to APOL1 Risk Variants: Involvement of Two Distinct Processes.APOL1风险变异导致肾脏疾病的机制:两个不同过程的参与
J Am Soc Nephrol. 2024 Jun 1;35(6):818-821. doi: 10.1681/ASN.0000000000000367. Epub 2024 Apr 10.
10
Protein-truncating variant in APOL3 increases chronic kidney disease risk in epistasis with APOL1 risk alleles.APOL3 蛋白截断变异与 APOL1 风险等位基因的共显性作用增加了慢性肾脏病的风险。
JCI Insight. 2024 Oct 8;9(19):e181238. doi: 10.1172/jci.insight.181238.
ATG9A 通过 Arfaptin 2 和磷脂酰肌醇 4-激酶 IIIβ 塑造形成的自噬体。
J Cell Biol. 2019 May 6;218(5):1634-1652. doi: 10.1083/jcb.201901115. Epub 2019 Mar 27.
4
Disruption of APOL1-miR193a Axis Induces Disorganization of Podocyte Actin Cytoskeleton.APOL1-miR193a 轴的破坏导致足细胞肌动蛋白细胞骨架紊乱。
Sci Rep. 2019 Mar 5;9(1):3582. doi: 10.1038/s41598-019-39376-y.
5
Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.招募载脂蛋白 L1 肾病风险变异体到脂滴可减轻细胞毒性。
Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3712-3721. doi: 10.1073/pnas.1820414116. Epub 2019 Feb 7.
6
APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R.载脂蛋白L1风险等位基因RNA通过激活蛋白激酶R导致肾毒性。
Commun Biol. 2018 Nov 7;1:188. doi: 10.1038/s42003-018-0188-2. eCollection 2018.
7
GOLPH3: a Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer.GOLPH3:一种作用于高尔基体的磷酸肌醇(4)磷酸效应物,它可调节囊泡运输并促进癌症的发展。
J Lipid Res. 2019 Feb;60(2):269-275. doi: 10.1194/jlr.R088328. Epub 2018 Sep 28.
8
Comparison of Postdonation Kidney Function Between Caucasian Donors and Low-risk APOL1 Genotype Living Kidney Donors of African Ancestry.白种人供体与低风险APOL1基因型非洲裔活体肾供体捐献后肾功能的比较。
Transplantation. 2018 Nov;102(11):e462-e463. doi: 10.1097/TP.0000000000002405.
9
APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.APOL1 风险变异通过增强内质网应激导致足细胞损伤。
Biosci Rep. 2018 Aug 29;38(4). doi: 10.1042/BSR20171713. Print 2018 Aug 31.
10
APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.APOL1:感染、选择和肾脏疾病所带来的平衡。
Trends Mol Med. 2018 Aug;24(8):682-695. doi: 10.1016/j.molmed.2018.05.008. Epub 2018 Jun 7.